US 8877204
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
granted A61KA61K2039/6031A61K2039/605
Quick answer
US patent 8877204 (Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes) held by University of Connecticut Health Center expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- University of Connecticut Health Center
- Grant date
- Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/6031, A61K2039/605, A61K38/1709, A61K38/57